Mark Murmello
About Mark Murmello
Mark Murmello is the Director of Manufacturing Science and Technology for Cell Therapy at Carisma Therapeutics. He has over a decade of experience in the biopharmaceutical industry, having previously held positions at Sanofi Pasteur and AES Clean Technology.
Work at Carisma Therapeutics
Mark Murmello currently holds the position of Director of Manufacturing Science and Technology for Cell Therapy at Carisma Therapeutics. He has been with the company since 2022, contributing to the advancement of cell therapy technologies. His role involves overseeing the manufacturing processes and ensuring the implementation of best practices in the production of cell therapies. Carisma Therapeutics is based in Philadelphia, Pennsylvania, where Murmello applies his extensive experience in the biopharmaceutical sector to enhance operational efficiency.
Previous Experience at Sanofi Pasteur
Mark Murmello worked at Sanofi Pasteur for a total of ten years, serving in various capacities. He began as the Lead Project Manager at AES Clean Technology from 2006 to 2008 before returning to Sanofi Pasteur. He held the position of Deputy Director from 2008 to 2018, followed by a role as Director - Product CMC Leader in Global Manufacturing Technology from 2018 to 2022. His tenure at Sanofi Pasteur involved significant contributions to manufacturing and product development in the biopharmaceutical field.
Education and Expertise
Mark Murmello earned a Bachelor of Science degree in Chemical Engineering from Lafayette College. He furthered his education by obtaining a Master of Business Administration (MBA) from Wilkes University School of Business and Leadership. His educational background provides a solid foundation in both engineering principles and business management, equipping him with the skills necessary for leadership roles in the manufacturing and technology sectors.
Career Timeline
Mark Murmello's career spans over 16 years in the biopharmaceutical and technology industries. He began his professional journey at AES Clean Technology as Lead Project Manager from 2006 to 2008. He then joined Sanofi Pasteur, where he held multiple roles, including Deputy Director and Director of Product CMC Leader in Global Manufacturing Technology. In 2022, he transitioned to Carisma Therapeutics, where he continues to apply his expertise in manufacturing science and technology.